|
ZNF182 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.10862446895044E-15 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.04558592287185E-12 |
| Normal-vs-Stage2 |
9.646800E-04 |
| Normal-vs-Stage3 |
3.83560000427607E-08 |
| Normal-vs-Stage4 |
4.45500000000321E-05 |
| Stage1-vs-Stage2 |
9.626000E-01 |
| Stage1-vs-Stage3 |
8.602400E-01 |
| Stage1-vs-Stage4 |
6.813000E-01 |
| Stage2-vs-Stage3 |
8.806400E-01 |
| Stage2-vs-Stage4 |
8.307000E-01 |
| Stage3-vs-Stage4 |
6.498400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.63391522534084E-12 |
| Normal-vs-AfricanAmerican |
3.012200E-04 |
| Normal-vs-Asian |
1.143690E-02 |
| Caucasian-vs-AfricanAmerican |
3.908800E-01 |
| Caucasian-vs-Asian |
1.886780E-01 |
| AfricanAmerican-vs-Asian |
6.310400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.7027490528676E-12 |
| Normal-vs-Female |
1.60469970644783E-10 |
| Male-vs-Female |
2.572800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.095710E-02 |
| Normal-vs-Age(41-60Yrs) |
1.2623235789988E-13 |
| Normal-vs-Age(61-80Yrs) |
1.48939971467144E-10 |
| Normal-vs-Age(81-100Yrs) |
6.084200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.374600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.851400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.529400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.891410E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.684600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.482000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.976480E-03 |
| Normal-vs-Grade 2 |
5.07482944556159E-13 |
| Normal-vs-Grade 3 |
5.94779780982435E-11 |
| Normal-vs-Grade 4 |
3.176300E-03 |
| Grade 1-vs-Grade 2 |
3.748200E-01 |
| Grade 1-vs-Grade 3 |
2.159400E-01 |
| Grade 1-vs-Grade 4 |
9.180300E-02 |
| Grade 2-vs-Grade 3 |
4.333400E-01 |
| Grade 2-vs-Grade 4 |
6.498200E-02 |
| Grade 3-vs-Grade 4 |
1.752380E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.78823622576374E-12 |
| Normal-vs-ccB subtype |
2.51010001672825E-09 |
| ccA subtype-vs-ccB subtype |
4.804000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.08020317322189E-12 |
| Normal-vs-N1 |
6.519500E-02 |
| N0-vs-N1 |
3.414200E-01 |
|
|
